Researchers at Los Angeles-based Cedars-Sinai’s Smidt Heart Institute have created an artificial intelligence tool that can identify and distinguish between two overlooked heart conditions: hypertrophic cardiomyopathy and cardiac amyloidosis, the institute said Feb. 23.
